SPOTLIGHT -
November 27th 2019
A real-time testing solution could lead to more precise treatment and better outcomes.
November 18th 2019
The firm will invest in biotech companies focused on drug discovery and development.
November 13th 2019
The platform could help create new treatments for patients with muscle disorders.
October 17th 2019
The partnership could improve the speed, cost and success rate of drug development.
October 11th 2019
New AI-enabled technologies can improve patient outcomes.
More Physicians Are Learning About Genetics, But That Doesn't Mean They're Confident
Genetic tests are booming, but can primary care providers keep up?
MyHeritage Data Breach: 4 Fast Facts
92 million accounts may have been exposed in a recent cybersecurity incident. Actually, 92,283,889, to be exact.
Sangamo Gets Green Light for UK Clinical Trials
The burgeoning gen-editing giant will test its zinc finger nuclease (ZFN) editing technology against lysosomal storage disorders in children.
Big Data Tool Represents Major Step for RNA Substructure Analysis
"An objective, precise, compact, unambiguous, easily-interpretable description of all loops, stems, and pseudoknots."
Telehealth Might Democratize Genetic Counseling (and Testing)
When offered remote counseling, patients were far more likely to be tested...and to have their potentially-risky variants identified.
Forensic Genealogy Is Neat. Is It Ethical, Though?
After genealogy data was used to make an arrest in the Golden State Killer case, NIH bioethicist Benjamin Berkman had some questions.
AI, Big Data Continue Big Year as OM1 Raises $21M
Why investors like the company’s high-tech approach to patient outcomes.
J. Craig Venter Moving On from Human Longevity
One of the world's most-recognized genomic scientists is retiring from the ambitious company that he founded.
Envisagenics Stays Hot With $1.5 Million NIH Grant
The AI and genetics company has been winning competitions and grants at a steady clip this year.
A Blockchain Genomic Data Start-Up Held Its ICO. 15 Seconds Later, It Had $35M
What made Shivom’s secure genome sequencing so tempting to investors?
Genomind Says Its Pharmacogenetic Testing Could Save Healthcare Thousands
The company just published new study results about the 6-month cost savings associated with a mental health drug efficacy assay.
Genoox Doubles Its All-Time Funding in New Venture Round
A new $6 million funding round led by Triventures could help the company in its efforts to democratize next-generation sequencing technology.
Macro Data for the Microbiome
The American Gut Project has inspired more than 10,000 people to mail fecal samples to UC San Diego. That's a good thing.
Why Orig3n Won't Sell Customer Genetic Data
During an interview at HLTH, CEO Robin Smith said his company had no interest in deciding who else could see a consumer's genetic info.
Defining "Normal" in the Age of Precision Medicine
There's more patient data out there than ever, but big data can create big problems.
5 Stories That Ignited Health Tech This Week
From big data’s role in solving coming healthcare problems to Comcast’s new partnership, these stories resonated with our readers.
With $125M Windfall, 10x Genomics Continues Gold Rush
Genomics has attracted heavy investment in recent years. Will it ever end?
What Does Comcast's New Deal Mean for Healthcare?
The cable and media giant will launch a pilot project with Independence Health to bring personalized health content and guidance to patients.
Think Healthcare Has Yet to Benefit from AI? 200K Patients Say Otherwise
SOPHiA Genetics, a Swiss health-tech company, is celebrating a diagnostics milestone and a $1.4 billion windfall for AI overseas.
Sangamo Receives $8 Million Grant from California's Stem Cell Research Fund
The funding will support the study of ST-400 as a cell therapy candidate for people with transfusion-dependent beta-thalassemia.
Original Research: CAR T Needs Data, but Healthcare Is Not Ready
Original research suggests that clinicians want their organizations to better embrace tech surrounding the therapy.
Leo Celi and the 'Holy Grail of Personalized Medicine'
Nearly everyone extols the need to bust data silos. Meet the man who’s doing it.
St. Jude Puts a Huge Pediatric Cancer Genomics Dataset in the Cloud
The publically-accessible repository, built alongside Microsoft and DNAnexus, is meant to spur research and collaboration to fight pediatric cancer.
Gottlieb Takes to Twitter for AI, Next Generation Sequencing Announcements
"Promoting and protecting public health requires FDA to adopt policies to ensure regulation serves as bridge to innovation, not a barrier to it," he tweeted.
Wave Life Sciences and Deep Genomics Join Up to Splice
The pair want to combine their chemistry and machine learning platforms to find targets for neuromuscular disease treatments.
Michigan County Looks to Genomics in the Fight Against Opioid Abuse
A new program there is armed with $750,000 in grant funding to look for answers in the assays.
Gene-Editing Start-Up Poseida Lands $30.5M to Advance CAR T
The precision medicine innovator plans to use the money to finance the second generation of the immunotherapies.
Singlera Genomics Adds Another $60 Million
Want to make an easy million, or 60? Just develop some proprietary genomics technologies for cancer detection and treatment.
Following Shakeup, Human Longevity Hires a CTO and Announces New Consumer Plans
Looking to grow its consumer-facing Health Nucleus platform, the genomics company announced a $25,000 plan that includes MRIs and a battery of other tests.
Study Finds 40% False Positives in Direct-to-Consumer Genetic Tests
“People may assume that they are being provided accurate medical grade testing, so understandably do not go to the trouble and expense of seeking confirmation.”